Henry Schein Inc. stock down on Q2 earnings, misses EPS but beats sales. Total net sales up 3.3%, $23M in restructuring costs. FY2025 guidance affirmed.
Latest Ratings for HSIC
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2022 | Morgan Stanley | Maintains | Underweight | |
| Feb 2022 | Credit Suisse | Maintains | Outperform | |
| Jan 2022 | Morgan Stanley | Initiates Coverage On | Underweight |
